Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Net Margin (2023 - 2025)

Historic Net Margin for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to 235.51%.

  • Metagenomi's Net Margin fell 724700.0% to 235.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 287.06%, marking a year-over-year decrease of 1527900.0%. This contributed to the annual value of 149.26% for FY2024, which is 32400.0% up from last year.
  • Per Metagenomi's latest filing, its Net Margin stood at 235.51% for Q3 2025, which was down 724700.0% from 233.85% recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Net Margin registered a high of 53.67% during Q2 2024, and its lowest value of 606.71% during Q1 2025.
  • Its 3-year average for Net Margin is 216.23%, with a median of 186.36% in 2023.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 610700bps in 2024, then tumbled by -3813500bps in 2025.
  • Over the past 3 years, Metagenomi's Net Margin (Quarter) stood at 155.61% in 2023, then tumbled by -56bps to 243.37% in 2024, then increased by 3bps to 235.51% in 2025.
  • Its last three reported values are 235.51% in Q3 2025, 233.85% for Q2 2025, and 606.71% during Q1 2025.